Compounding Chemotherapy Market Size, Share, Trends & Forecast
The Compounding Chemotherapy Market is growing as healthcare providers increasingly need customized chemotherapy preparations for patients with different dosage and treatment requirements. WiseGuyReports estimates the market at USD 9.48 billion in 2024 and projects it to reach USD 16.5 billion by 2032, with a 7.18% CAGR from 2025 to 2032.
Technology is moving toward safer and more precise chemotherapy preparation. Automated and robotic compounding systems, gravimetric and volumetric dosing technologies, and improved sterile processing are helping pharmacies reduce manual handling and improve consistency.
Hospitals and oncology centers are major users of compounded chemotherapy, while specialty pharmacies, outpatient care facilities, and home healthcare services are also becoming important. Customized preparations can support pediatric, geriatric, and other patients who require adjusted doses or formulations.
North America remains a major market because of its advanced healthcare infrastructure and established oncology services. Asia-Pacific is showing strong potential as cancer treatment capacity, pharmaceutical infrastructure, and personalized medicine programs expand across countries such as China, India, and Japan.
Future opportunities include robotic compounding, centralized pharmacy services, home-based chemotherapy support, and customized formulations for targeted therapies. Greater investment in sterile facilities and automation could further improve safety, efficiency, and scalability across oncology care.